Cargando…
Massively parallel functional testing of MSH2 missense variants conferring Lynch syndrome risk
The lack of functional evidence for the majority of missense variants limits their clinical interpretability and poses a key barrier to the broad utility of carrier screening. In Lynch syndrome (LS), one of the most highly prevalent cancer syndromes, nearly 90% of clinically observed missense varian...
Autores principales: | Jia, Xiaoyan, Burugula, Bala Bharathi, Chen, Victor, Lemons, Rosemary M., Jayakody, Sajini, Maksutova, Mariam, Kitzman, Jacob O. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7820803/ https://www.ncbi.nlm.nih.gov/pubmed/33357406 http://dx.doi.org/10.1016/j.ajhg.2020.12.003 |
Ejemplares similares
-
High-Throughput Splicing Assays Identify Known and Novel WT1 Exon 9 Variants in Nephrotic Syndrome
por: Smith, Cathy, et al.
Publicado: (2023) -
Benchmarking splice variant prediction algorithms using massively parallel splicing assays
por: Smith, Cathy, et al.
Publicado: (2023) -
Incomplete Segregation of MSH6 Frameshift Variants with Phenotype of Lynch Syndrome
por: Liccardo, Raffaella, et al.
Publicado: (2017) -
No Difference in Penetrance between Truncating and Missense/Aberrant Splicing Pathogenic Variants in MLH1 and MSH2: A Prospective Lynch Syndrome Database Study
por: Dominguez-Valentin, Mev, et al.
Publicado: (2021) -
Massively Parallel Single Amino Acid Mutagenesis
por: Kitzman, Jacob O., et al.
Publicado: (2015)